보도자료 · Press
The world is paying attention to the sugar meter... Dongwoon Anatech is aiming for a second leap forward.
It is time for 'on-site coverage' that focuses on listed companies that are expected to grow in the stock market.
Today, reporter Park Seung-won visited Dongwoon Anatech, which developed the world's first technology to measure sugar in the body with saliva, or saliva.
It is the world's first sugar meter 'Disalife' developed by Dongwoon Anatech, a semiconductor fabless company.
After biting the saliva collector in your mouth, drop the collected saliva on the test paper and put it in the reader to know the sugar level.
If the sugar level exceeds the normal standard, the reader's screen turns red, indicating the danger.
If you download the dedicated application to your mobile phone and link it with the reader, you can check the change in sugar levels and receive various information such as exercise.
The advantage is that semiconductor technology is applied to eliminate the pain of extracting existing blood with high accuracy.
Already, the results of the first exploratory clinical trial in 2020 were selected as a paper published by the world's prestigious diabetes association in September, proving its technological prowess.
Dongwoon Anatech has recently started a second exploratory clinical trial by increasing the number of patients to make products with higher accuracy.
After completing the second exploratory clinical trial early next year, the goal is to commercialize it in the second half of next year after approval from the main clinical trial and the Ministry of Food and Drug Safety.
[Kim Dong-cheol, CEO of Dongwoon Anatech] I'd like to get certification through the 2nd exploratory clinical trial. We have a plan to receive the main clinical trial required by the Ministry of Food and Drug Safety, approve it by the Ministry of Food and Drug Safety, and then mass-produce it in the second half of next year at most in the fourth quarter.]
At the same time as domestic approval, we plan to prepare a strategy to enter the global market.
Among them, the United States, the world's largest pharmaceutical market, is the most notable.
[Kim Dong-cheol, CEO of Dongwoon Anatech: Next year, in addition to obtaining approval from the Ministry of Food and Drug Safety in Korea, we are going to focus on obtaining approval from the U.S. FDA (Food and Drug Administration). So we're planning to expand this business globally based on FDA approval.]
Dongwoon Anatech is on track for its digital healthcare business.
Based on sales in the semiconductor sector along with sales in the fourth quarter of this year, the company plans to achieve more than 50% growth next year than this year.
I'm Park Seungwon of Korea Economic TV.
Korea Economic TV reporter Park Seung-won / https://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202211140234&t=NNv
